CONDENSED CONSOLIDATED STATEMENTS OF CONTINGENTLY REDEEMABLE COMMON STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	AOCI Attributable to Parent [Member]	Noncontrolling Interests	Contingently Redeemable Common Stock	IPO	IPO Common Stock	IPO Additional Paid-In Capital	IPO Contingently Redeemable Common Stock
Beginning balance at Dec. 31, 2020	$ (284,730)	$ 2,494	$ 263,966	$ (551,190)		$ 0
Contingently Redeemable Common Stock, Beginning balance, shares at Dec. 31, 2020							76,201,000
Contingently Redeemable Common Stock, Beginning balance at Dec. 31, 2020							$ 309,500
Beginning balance, shares at Dec. 31, 2020		249,374,000
Net income (loss)	(350,050)			(349,766)		(284)
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO"), Shares									76,201,000		76,201,000
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO")								$ 309,500	$ 762	$ 308,738	$ (309,500)
Issuance of common stock in connection with IPO, net of offering costs, Shares									53,590,000
Issuance of common stock in connection with IPO, net of offering costs								1,163,133	$ 536	1,162,597
Issuance of common stock under partner physician group equity agreements upon IPO, Shares									11,672,000
Issuance of common stock under partner physician group equity agreements upon IPO								$ 268,467	$ 117	$ 268,350
Exercise of stock options and other, net	1,606	$ 6	1,600
Exercise of stock options and other, net, shares		711,000
Stock-based compensation expense	19,513		19,513
Ending balance at Sep. 30, 2021	1,127,439	$ 3,915	2,024,764	(900,956)		(284)
Contingently Redeemable Common Stock, Ending balance, shares at Sep. 30, 2021							0
Contingently Redeemable Common Stock, Ending balance at Sep. 30, 2021							$ 0
Ending balance, shares at Sep. 30, 2021		391,548,000
Beginning balance at Jun. 30, 2021	1,150,278	$ 3,909	2,011,651	(865,113)		(169)
Beginning balance, shares at Jun. 30, 2021		390,883,000
Net income (loss)	(35,958)			(35,843)		(115)
Exercise of stock options and other, net	1,055	$ 6	1,049
Exercise of stock options and other, net, shares		665,000
Stock-based compensation expense	11,960		11,960
Offering cost in connection with public offering	104		104
Ending balance at Sep. 30, 2021	1,127,439	$ 3,915	2,024,764	(900,956)		(284)
Contingently Redeemable Common Stock, Ending balance, shares at Sep. 30, 2021							0
Contingently Redeemable Common Stock, Ending balance at Sep. 30, 2021							$ 0
Ending balance, shares at Sep. 30, 2021		391,548,000
Beginning balance at Dec. 31, 2021	$ 1,091,596	$ 4,001	2,045,572	(957,677)		(300)
Beginning balance, shares at Dec. 31, 2021	400,095,000	400,095,000
Net income (loss)	$ (50,315)			(50,087)		(228)
Exercise of stock options and other, net	31,462	$ 113	31,349
Exercise of stock options and other, net, shares		11,392,000
Other comprehensive income (loss)	$ (5,098)				(5,098)
Costs of RSU Vestings, Shares		289,000
Costs of RSU Vestings		$ 3	$ (3)
Shares withheld related to net share settlement, Shares		35,000
Shares withheld related to net share settlement	(786,000)		(786,000)
Stock-based compensation expense	$ 18,430		$ 18,430
Ending balance at Sep. 30, 2022	$ 1,085,289	$ 4,117	2,094,562	(1,007,764)	(5,098)	(528)
Ending balance, shares at Sep. 30, 2022	411,741,000	411,741,000
Beginning balance at Jun. 30, 2022	$ 1,103,371	$ 4,082	2,076,329	(977,096)	513	(457)
Beginning balance, shares at Jun. 30, 2022		408,204,000
Net income (loss)	(30,739)			(30,668)		(71)
Exercise of stock options and other, net	10,389	$ 33	10,356
Exercise of stock options and other, net, shares		3,390,000
Other comprehensive income (loss)	$ (5,611)				(5,611)
Costs of RSU Vestings, Shares		149,000
Costs of RSU Vestings		$ 2	$ (2)
Shares withheld related to net share settlement, Shares		2,000
Shares withheld related to net share settlement	(28,000)		(28,000)
Stock-based compensation expense	$ 7,907		$ 7,907
Ending balance at Sep. 30, 2022	$ 1,085,289	$ 4,117	$ 2,094,562	$ (1,007,764)	$ (5,098)	$ (528)
Ending balance, shares at Sep. 30, 2022	411,741,000	411,741,000